Yerem Yeghiazarians, MD profile page

Yerem Yeghiazarians, M.D., is co-founder and chief executive officer of Soley Therapeutics. A clinician scientist with more than two decades of experience in cardiology, stem cell biology, and translational research, he leads Soley’s biology-first discovery strategy and guides the company’s evolution from foundational science into a clinical-stage organization. Before founding Soley, Dr. Yeghiazarians served as professor of medicine at the University of California, San Francisco, where he founded and directed the Translational Cardiac Stem Cell Program and held the Leone-Perkins Family Endowed Chair in Cardiology. His work helped establish the infrastructure for cardiac stem cell research at UCSF and advanced understanding of how stressed cells sense and respond to their environment, forming the scientific basis of Soley’s platform. Over his academic career, Dr. Yeghiazarians published more than 110 peer-reviewed papers and edited two books, with contributions spanning cardiac regeneration, cellular stress biology, and mechanisms of cell fate. He also served as President of the American Heart Association in the San Francisco Bay Area and was an Associate Member of the Experimental Therapeutics Program at the UCSF Helen Diller Cancer Center. Dr. Yeghiazarians earned his B.A. in biology and biochemistry from Brandeis University and his M.D. from the Johns Hopkins School of Medicine. He completed his residency, chief residency, cardiology fellowship, and interventional cardiology training at Brigham and Women’s Hospital, Harvard Medical School.